Expediting Drug Development Regulatory Pathways Globally

Read more

In the following Clinical Researcher article, Worldwide Clinical Trials’ Global Head of Regulatory Strategy, Aman Khera, discusses how global regulatory agencies are acting as a supportive resource for sponsors through accommodations for industry advancements such as new technologies and expanding expedited pathways for drug development.


VP, Regulatory Science, Strategy and Innovation

Want to learn more about Worldwide Clinical Trials?